Literature DB >> 11857344

Requirement for both IL-12 and IFN-gamma signaling pathways in optimal IFN-gamma production by human T cells.

Giuliana Losana1, Laura Rigamonti, Igor Borghi, Barbara Assenzio, Silvia Ariotti, Emmanuelle Jouanguy, Frederic Altare, Guido Forni, Jean-Laurent Casanova, Francesco Novelli.   

Abstract

Phytohemagglutinin (PHA)-derived T lymphoblasts or T cell clones from patients genetically deficient in IL-12R beta 1 (IL-12R beta 1(-/-)) or IFN-gamma R1 (IFN-gamma R1(-/-)) produced two- to threefold reduced IFN-gamma levels compared to the corresponding cells from healthy individuals after anti-CD3 and PMA stimulation. Moderate IFN-gamma production was observed in PHA-derived T lymphoblasts or T cell clones derived from healthy subjects in the presence of anti-IFN-gamma R1 or anti-IL-12 mAb, whereas it was negligible in the presence of both mAb. However, when anti-IFN-gamma R1 and/or anti-IL-12 mAb were added during restimulation, the cells produced normal levels of IFN-gamma, indicating that both IFN-gamma and IL-12 had an effect on the priming phase. Moderate production of IFN-gamma was partially enhanced only in IFN-gamma R1(-/-) T cell clones generated in the presence of IL-12, but was almost completely abolished when IL-12R beta 1(-/-) and IFN-gamma R1(-/-) T cell clones were generated in the presence of anti-IFN-gamma R1 or anti-IL-12 mAb, respectively. IL-4 production was enhanced in T cell clones from IL-12R beta 1(-/-),but not from IFN-gamma R1(-/-) patients, whereas IL-10 and IL-2 production did not differ significantly in polyclonal T cells or clones from healthy and deficient individuals. These results indicate that IL-12R beta 1- and IFN-gamma R1-dependent signals co-ordinately regulate IFN-gamma, but not IL-2 and IL-10 production, whereas only IL-12 negatively controls IL-4 production by in vitro-generated T cell clones. Thus, although IL-12 and IFN-gamma signals are each sufficient for moderate production of IFN-gamma by human T cells, both are needed for optimal IFN-gamma production, and in the absence of both IFN-gamma production is completely abrogated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857344     DOI: 10.1002/1521-4141(200203)32:3<693::AID-IMMU693>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis.

Authors:  Shreeram Akilesh; Daniel J Shaffer; Derry Roopenian
Journal:  Genome Res       Date:  2003-07       Impact factor: 9.043

2.  Inherited defects in the interferon-gamma receptor or interleukin-12 signalling pathways are not sufficient to cause allergic disease in children.

Authors:  Philip M D Wood; Claire Fieschi; Capucine Picard; Tom H M Ottenhoff; Jean-Laurent Casanova; Dinakantha S Kumararatne
Journal:  Eur J Pediatr       Date:  2005-08-23       Impact factor: 3.183

3.  Variable outcome of experimental interferon-gamma therapy of disseminated Bacillus Calmette-Guerin infection in two unrelated interleukin-12Rbeta1-deficient Slovakian children.

Authors:  Timo Ulrichs; Claire Fieschi; Eva Nevicka; Helmut Hahn; Martin Brezina; Stefan H E Kaufmann; Jean-Laurent Casanova; Klara Frecerova
Journal:  Eur J Pediatr       Date:  2005-01-05       Impact factor: 3.183

4.  Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with Talaromyces marneffei Infections.

Authors:  Zhao-Ming Chen; Xiao-Yun Yang; Zheng-Tu Li; Wei-Jie Guan; Ye Qiu; Shao-Qiang Li; Yang-Qing Zhan; Zi-Ying Lei; Jing Liu; Jian-Quan Zhang; Zhong-Fang Wang; Feng Ye
Journal:  Infect Drug Resist       Date:  2022-06-28       Impact factor: 4.177

Review 5.  [Immunology of tuberculosis: impact on the development of novel vaccines].

Authors:  T Ulrichs; S H E Kaufmann
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743

6.  Expression of functional interleukin-12 from mouse in transgenic tomato plants.

Authors:  Abel Gutiérrez-Ortega; Claudia Sandoval-Montes; Teresa Jesús de Olivera-Flores; Leopoldo Santos-Argumedo; Miguel Angel Gómez-Lim
Journal:  Transgenic Res       Date:  2005-12       Impact factor: 3.145

Review 7.  The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease.

Authors:  David Bastian; Yongxia Wu; Brian C Betts; Xue-Zhong Yu
Journal:  Front Immunol       Date:  2019-05-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.